Patent · US Active

Compositions of asymmetric interfering RNA and uses thereof

US9328345B2 · kind B2 · utility

31Cited by
0References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 27, 2008
Grant dateMay 3, 2016
Priority date
Expiry dateFeb 25, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2330/51
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides asymmetrical duplex RNA molecules that are capable of effecting sequence-specific gene silencing. The RNA molecule comprises a first strand and a second strand. The first strand is longer than the second strand. The RNA molecule comprises a double-stranded region formed by the first strand and the second strand, and two ends independently selected from the group consisting of 5′-overhang, 3′-overhang, and blunt end. The RNA molecules of the present invention can be used as research tools and/or therapeutics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.